Alnylam Pharmaceuticals reported $1.23M in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 71K 0
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Amgen AMGN:US USD 32.37B 1.03B
Arrowhead Research ARWR:US USD 198K 0
Avrobio Inc AVRO:US USD 4K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
IONIS PHARMACEUT IONS:US USD 142K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Moderna Inc MRNA:US USD 38.7K 500
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NVS:US USD 890M 0
Ptc Therapeutics PTCT:US USD 71K 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Regulus Therapeutics RGLS:US USD 17K 2K
Sangamo Biosciences SGMO:US USD 1.62M 85K
Sarepta Therapeutics SRPT:US USD 9K 0
Takeda 4502:JP JPY 1.68T 53M
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Xencor XNCR:US USD 598K 0
YTE INCY:US USD 222K 0